Kahar, Nasrin A.

HRN: 03-06-29  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/30/2025
CLINDAMYCIN 150MG/ML, 4ML (AMP)
05/30/2025
06/06/2025
IV
600mg
Q6
Fracture, Thumb, Right
Waiting Final Action 

Indication:  ProphylaxisEmpiric    Type of Infection:  Bone & Joint    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: